TNFRSF1B and breast cancer: It contributes to shared inflammatory pathways by promoting a pro-inflammatory microenvironment, and the presence of missense mutations in TNFRSF1B among BC patients with diabetes may exacerbate both tumor progression and metabolic dysfunction.